New Weapon Against Malaria
For the 2% of patients who develop cerebral malaria, a severe and often fatal strain of the disease, a Toronto-based study being conducted in Uganda may hold out hope.
For the 2% of patients who develop cerebral malaria, a severe and often fatal strain of the disease, a Toronto-based study being conducted in Uganda may hold out hope.
The term ‘motion sickness’ is a bit of a misnomer: it isn’t really due to ‘motion’ per se, and it isn’t really a ‘sickness’ in the disease sense of the term.
Medcan's Director of Global Health Dr. Kevin Kain and his research team have made discoveries that hold promise to improve the outcome of children and adults with malaria.
Dr. Kevin Kain, Director of Global Health at the Medcan Clinic and his research
As part of Melanoma Awareness month, real people address
About half of the world's population is at risk for contracting malaria
People often think about vaccinations when travelling to places like Africa, India and South America, but often overlook them when travelling south for a winter holiday - particularly when they are staying at a 5-star resort.